Labiotech.eu (blog)Taking CAR-T Cells Beyond Cancer: A New Therapy for Autoimmune DiseaseLabiotech.eu (blog)CAR-T cells are all the rage as the latest treatment for cancer. But what if we could apply this same technology to treat autoimmune disease? Cu… Continue reading
Labiotech.eu (blog)Taking CAR-T Cells Beyond Cancer: A New Therapy for Autoimmune DiseaseLabiotech.eu (blog)CAR-T cells are all the rage as the latest treatment for cancer. But what if we could apply this same technology to treat autoimmune disease? Cu… Continue reading
GeekWire |
Former VP Joe Biden comes out swinging for science and his cancer moonshot
GeekWire “We’re now firmly in the realm of synthetic biology,” said Rafael Ponce, senior director of preclinical science for Juno Therapeutics. Juno Therapeutics, which was spun out from a consortium of cancer centers in 2013, has been through a series of sharp … |
Nasdaq |
AstraZeneca’s immunotherapy drug wins key lung cancer approval …
Nasdaq LONDON, Feb 17 (Reuters) – AstraZeneca’s immunotherapy drug Imfinzi has won crucial approval from U.S. regulators for use in lung cancer, opening up a multibillion-dollar market for a medicine that has so far lagged behind competitors. The U.S. Food … Immunotherapy Drug Wins Key Lung Cancer OK | Newsmax.comNewsmax UPDATE 2-AstraZeneca’s immunotherapy drug wins key lung cancer approvalLondon South East (blog) AstraZeneca’s cancer therapy Imfinzi gets FDA nodMarketWatch Chicago Evening Post –The Times all 12 news articles » |
Nasdaq |
AstraZeneca’s immunotherapy drug wins key lung cancer approval …
Nasdaq LONDON, Feb 17 (Reuters) – AstraZeneca’s immunotherapy drug Imfinzi has won crucial approval from U.S. regulators for use in lung cancer, opening up a multibillion-dollar market for a medicine that has so far lagged behind competitors. The U.S. Food … Immunotherapy Drug Wins Key Lung Cancer OK | Newsmax.comNewsmax UPDATE 2-AstraZeneca’s immunotherapy drug wins key lung cancer approvalLondon South East (blog) AstraZeneca’s cancer therapy Imfinzi gets FDA nodMarketWatch Chicago Evening Post –The Times all 12 news articles » |
Newsmax |
Immunotherapy Drug Wins Key Lung Cancer OK
Newsmax AstraZeneca’s immunotherapy drug Imfinzi has won crucial approval from U.S. regulators for use in lung cancer, opening up a multibillion-dollar market for a medicine that has so far lagged behind competitors. The U.S. Food and Drug Administration said … |